FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to a compound or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of: isopropyl-(Z)-7-((1R,2R,3R,5S)-3,5-bis(nitrooxy)-2-((R,E)-3-(nitrooxy)-4-(3-(trifluoromethyl))phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate and (Z)-2-((((Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoyl)oxy)methoxy)-1-(pyrrolidin-1-yl)diazene-1-oxide.
EFFECT: said compounds can be used in ophthalmology.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHOSPHODIESTERASE TYPE 5 INHIBITOR RELEASING NITROGEN OXIDE | 2019 |
|
RU2785776C2 |
| PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES | 2012 |
|
RU2596867C2 |
| CYTOSKELETALLY ACTIVE RHO-KINASE INHIBITING COMPOUNDS, COMPOSITIONS AND USE THEREOF | 2007 |
|
RU2470928C2 |
| SUBSTITUTED CYCLOPENTANES, POSSESSING PROSTAGLANDIN ACTIVITY | 2009 |
|
RU2505530C2 |
| 2,6-DIAMINOPYRIDINE COMPOUNDS FOR TREATING AMYLOID PROTEIN RELATED PROTEINS AND FOR TREATING OCULAR DISEASES | 2010 |
|
RU2538208C2 |
| SULFONAMIDE COMPOUND | 2006 |
|
RU2376300C1 |
| NEW COMPOUNDS FOR TREATING AMYLOID OR AMYLOID-LIKE PROTEIN ASSOCIATED DISEASES | 2007 |
|
RU2469026C2 |
| CYTOSKELETON-ACTIVE COMPOUNDS, COMPOSITIONS AND USE | 2006 |
|
RU2407745C2 |
| AROMATIC DERIVATIVES OF SULFANILAMIDES CARBONIC ANHYDRASE II (CA II) INHIBITORS, METHODS FOR PRODUCTION AND USE THEREOF | 2015 |
|
RU2607630C1 |
| TRIAZINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES | 2015 |
|
RU2692789C2 |
